Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Partner, Sell or IPO? West Michigan Life Sciences Companies Weigh Complex Next Steps

Tuesday, November 1, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

At some point in the coming months, Mark Gurney and directors at  Tetra Discovery Partners LLC will decide which road to travel into the future for their company.

On the table for the five-year-old drug developer are three options for completing its commercialization journey. The firm could bring in a deep-pocketed strategic partner or cut a deal with a pharmaceutical maker for a structured buyout should Tetra meet set milestones in its drug development. The third option: Tetra could float an initial public offering, or IPO, to raise the capital needed to get to market on its own.

“We’re exploring all options,” said Gurney, the CEO of Tetra Discovery Partners, a firm involved in clinical trials on compounds to treat Alzheimer’s disease and memory impairment.

Read full article.


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal